Détail - canceropole-wordpress

Case report: Extremely rare case of poroma on the inner canthus.

Kayser E, Garbar C, Cortese S, Beulque E, Dolivet G, Mastronicola R

Int J Surg Case Rep. 2025 03 12;129:111140

Case report: Rare case of recurring cervical sialolipoma.

Kayser E, Garbar C, Cortese S, Beulque E, Dolivet G, Mastronicola R

Int J Surg Case Rep. 2025 03 12;129:111143

The NFAT3/RERG Complex in Luminal Breast Cancers Is Required to Inhibit Cell Invasion and May Be Correlated With an Absence of Axillary Lymph Nodes Colonization.

Coillard L, Guaddachi F, Ralu M, Brabencova E, Garbar C, Bensussan A, Le Bras M, Lehmann-Che J, Jauliac S

Front Oncol. 2022 06 30;12:804868

One-year COVID-19 outcomes on the oncology care patient pathway: Results of a French descriptive, cross-sectional comprehensive study (ONCOCARE-COV).

Laurent L, Brugel M, Carlier C, Clere F, Bertrand A, Botsen D, Boulagnon-Rombi C, Dalstein V, Debreuve-Theresette A, Deguelte S, Garbar C, Mahmoudi R, Marechal A, Morland D, Rey JB, Schvartz C, Vallet C, Merrouche Y, Slimano F, Bouché O

Cancer Med. 2022 05 20;:

The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma.

Gauci ML, Giustiniani J, Lepelletier C, Garbar C, Thonnart N, Dumaz N, Foussat A, Lebbé C, Bensussan A, Marie-Cardine A

Cancer Immunol Immunother. 2022 Apr 15;:

Apelin expression deficiency in mice contributes to vascular stiffening by extracellular matrix remodeling of the aortic wall.

Romier B, Dray C, Vanalderwiert L, Wahart A, Hocine T, Dortignac A, Garbar C, Garbar C, Boulagnon C, Bouland N, Maurice P, Bennasroune A, Sartelet H, Martiny L, Duca L, Valet P, Blaise S

Sci Rep. 2021 Nov 15;11(1):22278

Assessment of the Grisotti oncoplastic procedure for the management of central breast tumors.

Dabiri C, Hotton J, Wehbe K, Gornes H, Garbar C, Guillemin F, Ceccato V

Breast J. 2021 Jul 12;:

Primary gastric synovial sarcoma: A case report and literature review.

Marchand Crety C, Bellefqih S, Amroun K, Garbar C, Felici F

Int J Surg Case Rep. 2020 Dec 26;78:270-273

In vivo anti-MUC1 tumor activity and sequences of high-affinity anti-MUC1-SEA antibodies.

Pichinuk E, Chalik M, Benhar I, Ginat-Koton R, Ziv R, Smorodinsky NI, Haran G, Garbar C, Bensussan A, Meeker A, Guillaume T, Rubinstein DB, Wreschner DH

Cancer Immunol. Immunother.. 2020 Mar 26;:

Decreased expression of GPC1 in human skin keratinocytes and epidermis during ageing.

Perrot G, Colin-Pierre C, Ramont L, Proult I, Garbar C, Bardey V, Jeanmaire C, Mine S, Danoux L, Berthélémy N, Maquart FX, Wegrowski Y, Brézillon S

Exp. Gerontol.. 2019 Aug 17;:110693

[GEFPICS' guidelines for management of breast cancer tissue samples in the neoadjuvant setting].

Maran-Gonzalez A, Franchet C, Duprez-Paumier R, Antoine M, Barlier C, Becette V, Berghian A, Blanc-Fournier C, Brabencova E, Charafe-Jauffret E, Chenard MP, Dauplat MM, Delrée P, Fleury C, Garbar C, Ghnassia JP, Haudebourg J, MacGrogan G, Mathieu MC, Michenet P, Penault-Llorca F, Poulet B, Robin Y, Roger P, Russ E, Treilleux I, Valent A, Verriele V, Vincent-Salomon A, Arnould L, Lacroix-Triki M,

Ann Pathol. 2019 Jun 27;:

The Interleukin-17 Family of Cytokines in Breast Cancer.

Fabre JAS, Giustinniani J, Garbar C, Merrouche Y, Antonicelli F, Bensussan A

Int J Mol Sci. 2018 Dec 4;19(12):

Elastin molecular aging promotes MDA-MB-231 breast cancer cell invasiveness.

Salesse S, Odoul L, Chazée L, Garbar C, Duca L, Martiny L, Mahmoudi R, Debelle L

FEBS Open Bio. 2018 Sep;8(9):1395-1404

Adjuvant radiation therapy for malignant Abrikossoff's tumor: a case report about a femoral triangle localisation.

Marchand Crety C, Garbar C, Madelis G, Guillemin F, Soibinet Oudot P, Eymard JC, Servagi Vernat S

Radiat Oncol. 2018 Jun 20;13(1):115

CD160 Expression in Retinal Vessels Is Associated With Retinal Neovascular Diseases.

Henry A, Boulagnon-Rombi C, Menguy T, Giustiniani J, Garbar C, Mascaux C, Labrousse M, Milas C, Barbe C, Bensussan A, Durlach V, Arndt C

Invest. Ophthalmol. Vis. Sci.. 2018 Jun 1;59(7):2679-2686

Triple-negative and HER2-overexpressing breast cancer cell sialylation impacts tumor microenvironment T-lymphocyte subset recruitment: a possible mechanism of tumor escape.

Garbar C, Mascaux C, Merrouche Y, Bensussan A

Cancer Manag Res. 2018 ;10:1051-1059

Chemotherapy treatment induces an increase of autophagy in the luminal breast cancer cell MCF7, but not in the triple-negative MDA-MB231.

Garbar C, Mascaux C, Giustiniani J, Merrouche Y, Bensussan A

Sci Rep. 2017 Aug;7(1):7201

Aging decreases collagen IV expression in vivo in the dermo-epidermal junction and in vitro in dermal fibroblasts: possible involvement of TGF-β1.

Feru J, Delobbe E, Ramont L, Brassart B, Terryn C, Dupont-Deshorgue A, Garbar C, Monboisse JC, Maquart FX, Brassart-Pasco S

Eur J Dermatol. 2016 Aug;26(4):350-60

Digital holographic microscopy as screening tool for cervical cancer preliminary study.

Benzerdjeb N, Garbar C, Camparo P, Sevestre H

Cancer Cytopathol. 2016 Aug;124(8):573-80

IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells.

Merrouche Y, Fabre J, Cure H, Garbar C, Fuselier C, Bastid J, Antonicelli F, Al-Daccak R, Bensussan A, Giustiniani J

Oncotarget. 2016 Aug;7(33):53350-53361

Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type.

Fabre J, Giustiniani J, Garbar C, Antonicelli F, Merrouche Y, Bensussan A, Bagot M, Al-Dacak R

Int J Mol Sci. 2016 Aug;17(9):

Incidental Detection of Oxyphilic Papillary Thyroid Carcinoma by 18F-Fluorocholine PET/CT.

Lalire P, Zalzali M, Garbar C, Bruna-Muraille C, Morland D

Clin Nucl Med. 2016 Jun;41(6):512-3

Identification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytes.

De Masson A, Giustiniani J, Marie-Cardine A, Bouaziz JD, Dulphy N, Gossot D, Validire P, Tazi A, Garbar C, Bagot M, Merrouche Y, Bensussan A

Oncoimmunology. 2016 May;5(5):e1127493

MUC1-ARF-A Novel MUC1 Protein That Resides in the Nucleus and Is Expressed by Alternate Reading Frame Translation of MUC1 mRNA.

Chalick M, Jacobi O, Pichinuk E, Garbar C, Bensussan A, Meeker A, Ziv R, Zehavi T, Smorodinsky NI, Hilkens J, Hanisch FG, Rubinstein DB, Wreschner DH

PLoS ONE. 2016 ;11(10):e0165031

Is it important to adapt neoadjuvant chemotherapy to the visible clinical response? An open randomized phase II study comparing response-guided and standard treatments in HER2-negative operable breast cancer.

Wang-Lopez Q, Mouret-Reynier MA, Savoye AM, Abrial C, Kwiatkowski F, Garbar C, DuBray-Longeras P, Eymard JC, Lebouedec G, Vanpraagh I, Penault-Llorca F, Chollet P, Cure H

Oncologist. 2015 Mar;20(3):243-4

Autophagy is decreased in triple-negative breast carcinoma involving likely the MUC1-EGFR-NEU1 signalling pathway.

Garbar C, Mascaux C, Giustiniani J, Salesse S, Debelle L, Antonicelli F, Merrouche Y, Bensussan A

Int J Clin Exp Pathol. 2015 May 1;8(5):4344-55. eCollection 2015.

IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells.

Mombelli S, Cochaud S, Merrouche Y, Garbar C, Antonicelli F, Laprevotte E, Alberici G, Bonnefoy N, Eliaou JF, Bastid J, Bensussan A, Giustiniani J

Sci Rep. 2015 Jul 8;5:11874

Prognostic factors in operable breast cancer treated with neoadjuvant chemotherapy: towards a quantification of residual disease.

Mombelli S, Kwiatkowski F, Abrial C, Wang-Lopez Q, de Boissieu P, Garbar C, Bensussan A, Curé H

Oncology. 2015 ;88(5):261-72

[2014 update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France].

Penault-Llorca F, Vincent-Salomon A, MacGrogan G, Roger P, Treilleux I, Valent A, Mathieu MC, Antoine M, Becette V, Bor C, Brabencova E, Charafe-Jauffret E, Chenard MP, Dauplat MM, Delree P, Devouassoux M, Fiche M, Fondrevelle ME, Fridman V, Garbar C, Genin P, Ghnassia JP, Haudebourg J, Laberge-Le Couteulx S, Loussouarn D, Maran-Gonzalez A, Marcy M, Michenet P, Poulet B, Sagan C, Trassard M, Verriele V, Arnould L, Lacroix-Triki M

Ann Pathol. 2014 Oct;34(5):352-65

The human epidermal growth factor receptor 2 screening tests for breast cancer suggested by the new updated recommendation of the american society of clinical oncology/college of american pathologists will involve a rise of the in-situ hybridization tests

Garbar C, Savoye AM, Mascaux C, Brabencova E, Curé H

ISRN Oncol. 2014 ;2014:793695

Elastin-derived peptides are new regulators of insulin resistance development in mice.

Blaise S, Romier B, Kawecki C, Ghirardi M, Rabenoelina F, Baud S, Duca L, Maurice P, Heinz A, Schmelzer CE, Tarpin M, Martiny L, Garbar C, Dauchez M, Debelle L, Durlach V

Diabetes. 2013 Nov;62(11):3807-16

Inter-laboratory variability in the presence of human papillomavirus in normal and abnormal cervical cytology samples.

Weyn C, Garbar C, Noel JC, Weynand B, Verhest A, d'Olne D, Arbyn M, Englert Y, Fontaine V

Cancer Epidemiol. 2013 Aug;37(4):457-61

Fine-needle aspiration cytology can play a role in neoadjuvant chemotherapy in operable breast cancer.

Garbar C, Cure H

ISRN Oncol. 2013 Jul 10;2013:935796

IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2.

Cochaud S, Giustiniani J, Thomas C, Laprevotte E, Garbar C, Savoye AM, Cure H, Mascaux C, Alberici G, Bonnefoy N, Eliaou JF, Bensussan A, Bastid J

Sci Rep. 2013 Dec 9;3:3456

Muc1/Cd227 immunohistochemistry in routine practice is a useful biomarker in breast cancers.

Garbar C, Mascaux C, Cure H, Bensussan A

J Immunoassay Immunochem. 2013;34(3):232-45

Metastasis of vulvar cancer in the breast.

Verfaillie G, Garbar C, Vanhoeij M, Breucq C, Lamote J

Acta Chir Belg. 2012 Nov-Dec;112(6):444-6.

Expression of MUC1 (Ma695) in noninvasive papillary urothelial neoplasm according to the 2004 World Health Organization classification of the noninvasive urothelial neoplasm. An immunologic tool for the pathologist?

Garbar C, Mascaux C

Anal Quant Cytol Histol. 2011 Oct;33(5):277-82.

Evaluation of contractile function and inotropic reserve with tissue velocity, strain and strain rate imaging in streptozotocin-induced diabetes.

Weytjens C, Cosyns B, D'hooge J, Droogmans S, Lahoutte T, Garbar C, Roossens B, Van Camp G

Eur J Echocardiogr. 2010 Aug;11(7):622-9

Dose dependency and reversibility of serotonin-induced valvular heart disease in rats.

Droogmans S, Roosens B, Cosyns B, Degaillier C, Hernot S, Weytjens C, Garbar C, Caveliers V, Pipeleers-Marichal M, Franken PR, Bossuyt A, Schoors D, Lahoutte T, Van Camp G

Cardiovasc Toxicol. 2009 Sep;9(3):134-41

Cyproheptadine prevents pergolide-induced valvulopathy in rats: an echocardiographic and histopathological study.

Droogmans S, Roosens B, Cosyns B, Degaillier C, Hernot S, Weytjens C, Garbar C, Caveliers V, Pipeleers-Marichal M, Franken PR, Lahoutte T, Schoors D, Van Camp G

Am J Physiol Heart Circ Physiol. 2009 Jun;296(6):H1940-8

Echocardiographic and histological assessment of age-related valvular changes in normal rats.

Droogmans S, Roosens B, Cosyns B, Hernot S, Weytjens C, Degaillier C, Garbar C, Caveliers V, Pipeleers-Marichal M, Franken PR, Bossuyt A, Lahoutte T, Schoors D, Van Camp G

Ultrasound Med Biol. 2009 Apr;35(4):558-65